Scitara joins BioPhorum global collaboration to drive scientific advancements in the biopharmaceutical sector

Scitara is leading next generation digital transformation in the lab and through collaboration hopes to share its knowledge of laboratory data integration

31 Jan 2022
Blake Forman
Content Creator

Industry news

Scitara, a proven innovator in laboratory digital transformation, has announced it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements.

Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry. One of the programs within the portfolio, The Lab of the Future, sets out an industry manifesto creating a pathway to unlock the value of the pharmaceutical and biopharmaceutical sectors by realizing strategic IT and data-driven objectives to bring the laboratory of the future to reality.

The Scitara goal is clear: to help companies in life sciences solve the laboratory data integration challenge that has stifled progress for decades. Its Scientific Integration Platform™ SIP™, a cloud native infrastructure, facilitates a modern, fully connected laboratory with data standardization, data mobility, system flexibility, easily customizable workflows, and adaptability to a dynamic laboratory ecosystem.

Chief Technical Officer (CTO) at Scitara, Geoff Gerhardt, comments on the move: “Bringing new drugs to market involves overcoming complex data management challenges in a highly regulated environment. Mobilizing scientific data from research through quality control (QC)/manufacturing is critical to accelerating the pace of bringing life-saving therapies to market. Digital technology has huge transformational potential, but regulatory barriers have delayed its adoption compared to other industries.

“Joining BioPhorum allows us to work in collaboration with other like-minded industry leaders to share our knowledge, decades of experience, and resources in data custodianship to help science turn data into useable knowledge.”

Lauren Morgan, IT Phorum Lead at BioPhorum added: “Scitara is leading next-generation digital transformation in the lab. This aligns perfectly with our strategic goal of creating an environment in which leaders in the international pharmaceutical and biopharmaceutical industries come together to share information and accelerate the pace of change – for the benefit of the whole industry.”

The Scitara SIP, powered by its Digital Lab Exchange DLX™, integrates scientific data across the enterprise and, together with artificial intelligence (AI) and analytics tools, provides scientists with new insights to drive faster decision making – delivering data integrity in a fully compliant platform to meet the strict needs of regulated markets.

As BioPhorum members, Scitara will participate in presentations and members-only events alongside other industry leaders, to further the group’s collective knowledge on the lab of the future.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

LIMSLIMS (Laboratory Information Management System) is an informatics software system used to improve the quality assurance and quality control (QA / QC) of data management. LIMS can be a standard for common lab workflows, such as commercial off the shelf systems (COTS), or customized for more specialized lab use. Systems are available for mainframe computers or PC.Integration ServicesIncorporate lab systems, software and equipment with integration services.Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Discovery SoftwareComputational techniques used in both the chemistry and biology aspects of drug discovery, for data acquisition, processing and storage. Software is used for analysis of pathways, target identification, genomics, proteomics, modelling, lead identification, compound analysis and drug modelling among many others. Development SoftwareComputational techniques used in both the chemistry and biology aspects of drug development, for data acquisition, data analysis, processing and storage. Software is used for analysis of ADME results, toxicology, clinical trials and regulatory processes. Chem / BioinformaticsCheminformatics and bioinformatics are computational techniques used in chemistry and biology, respectively, for data acquisition, processing and storage. Cheminformatics focuses on compound information, whereas bioinformatics is mainly applied to analysis and modeling of genomics, genetic and sequencing information. Hardware and software is available for data acquisition, analysis, management and storage.Laboratory ManagementLaboratory management involves overseeing the operations of a lab, ensuring compliance with safety regulations, optimizing workflows, and maintaining equipment. Efficient lab management is key to ensuring accurate results and minimizing downtime. Technologies like laboratory information management systems (LIMS) and automated lab equipment are helping labs streamline operations. Browse our peer-reviewed product directory to find the best laboratory management tools, compare products, read reviews, and get pricing directly from manufacturers.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.
Scitara joins BioPhorum global collaboration to drive scientific advancements in the biopharmaceutical sector